tert-butyl 4-{4-[4-(1-methyl-6-oxo-1,6-dihydro-[4,4']bipyrimidinyl-2-yloxy)piperidin-1-yl]phenyl}piperazine-1-carboxylate | 1264940-74-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: tert-butyl 4-{4-[4-(1-methyl-6-oxo-1,6-dihydro-[4,4']bipyrimidinyl-2-yloxy)piperidin-1-yl]phenyl}piperazine-1-carboxylate
• 英文别名: Tert-butyl 4-[4-[4-(1-methyl-6-oxo-4-pyrimidin-4-ylpyrimidin-2-yl)oxypiperidin-1-yl]phenyl]piperazine-1-carboxylate
• CAS: 1264940-74-0
• 化学式: C₂₉H₃₇N₇O₄
• 分子量: 547.657
• InChiKey: SSZFOXFDJYYDCO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  40
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  104
• 氢给体数：
  0
• 氢受体数：
  9

文献信息

• PYRIMIDONE DERIVATIVES
  申请人：Nakayama Kazuki

  公开号：US20120208797A1

  公开（公告）日：2012-08-16

  A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein Z represents nitrogen atom or C—X; X represents hydrogen atom or fluorine atom; R 1 is hydrogen atom or a C 1 -C 3 alkyl group; L represents single bond or a C 1 -C 6 alkylene group which may be substituted; Y represents single bond, sulfur atom, oxygen atom, NH, or the like; R 2 represents hydrogen atom or a cyclic group which may be substituted, which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).

  化合物的化学式为(I)或其药学上可接受的盐：其中，Z代表氮原子或C-X；X代表氢原子或氟原子；R1代表氢原子或C1-C3烷基；L代表单键或C1-C6烷基，可以被取代；Y代表单键、硫原子、氧原子、NH或类似物；R2代表氢原子或可以被取代的环状基团。该化合物用于预防和/或治疗由tau蛋白激酶1异常活性引起的疾病，例如神经退行性疾病（如阿尔茨海默病）。
• US9006232B2
  申请人：——

  公开号：US9006232B2

  公开（公告）日：2015-04-14